Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use

Annals of Epidemiology
Sarah J LowryNoel S Weiss

Abstract

We investigated the relationship between use of tricyclic antidepressants (TCAs) and risk of non-Hodgkin lymphoma (NHL). Previous studies provided some evidence of an association, but did not assess risk of NHL subtypes. Cases and controls were members of Group Health, an integrated healthcare delivery system. Cases were persons diagnosed with NHL between 1980 and 2011 at age 25 years or older; eight control subjects were matched to each case on age, sex, and length of enrollment. Information on previous TCA use was ascertained from automated pharmacy data. Conditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) for NHL, overall and for common subtypes, for various patterns of TCA use. We identified 2768 cases and 22,127 matched control subjects. We did not observe an appreciably increased risk of NHL among TCA ever-users compared to non-users (OR, 1.1; 95% CI, 1.0-1.2). Overall risk of NHL was associated to at most a small degree with longer-term use (OR, 1.2; 95% CI, 1.0-1.4; ≥10 prescriptions), high-dose use (OR, 1.1; 95% CI, 0.8-1.5; ≥50 mg), or non-recent use (OR, 1.0; 95% CI, 0.9 = 1.2; >5 years previously). TCA use was not associated with NHL subtypes, except chronic...Continue Reading

References

Aug 13, 2005·European Journal of Pain : EJP·Harald BreivikDerek Gallacher
Jan 5, 2006·Journal of the National Cancer Institute·K E SmedbyHans-Olov Adami
Apr 15, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christina A ClarkeElizabeth A Holly
Sep 16, 2006·Journal of Cutaneous Pathology·Novie Sroa, Cynthia M Magro
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·K E SmedbyJ Askling
Mar 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andrew E GrulichWendy Cozen
Mar 28, 2008·Cancer Causes & Control : CCC·Xuesong HanYawei Zhang
Jun 11, 2008·Cancer Causes & Control : CCC·J Daniel CarreonSophia S Wang
Jun 17, 2008·Epidemiology·S O DaltonS Friis
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R AndersonRichard D Gelber
Sep 18, 2008·Blood·Lindsay M MortonPatricia Hartge
Nov 20, 2008·Journal of Internal Medicine·K E SmedbyE Baecklund
Apr 15, 2009·International Journal of Cancer. Journal International Du Cancer·Lesley A AndersonEric A Engels
May 16, 2009·International Journal of Cancer. Journal International Du Cancer·Eva ErberLaurence N Kolonel
Nov 19, 2011·Journal of the American Geriatrics Society·Sascha DublinLisa A Jackson

Citations

Jun 13, 2016·Journal of Neuro-oncology·Megan M HerrDavid Q Rich

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.